PROK2 and colorectal carcinoma: Researchers have found that neutrophils from CRC samples strongly express Bv8/PROK2, while inhibition of G-CSF or Bv8/PROK2 can improve the efficacy of anti-VEGF antibodies and prevent the emergence of drug resistance.